HOE490 & T&E& COST OF AMARYL , METFORMIN IN DM TYPE II

锄490

• 批准号: 6263792
• 负责人: ROBERT HARRISON
• 金额: $ 1.48万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6263792
• 关键词: clinical research; combination chemotherapy; diabetes mellitus therapy; drug adverse effect; drug screening /evaluation; human subject; hypoglycemic agents; metformin; noninsulin dependent diabetes mellitus

The purpose of this research study is to compare the effectiveness, side effects, and cost differences of Amaryl alone, metformin alone, or a combination of lower doses of each in recent onset type 2 diabetes mellitus.

本研究的目的是比较单独使用 Amaryl、单独使用二甲双胍或较低剂量的组合治疗新近发病的 2 型糖尿病的有效性、副作用和成本差异。